Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declarati...
Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki
About this item
Full title
Author / Creator
Publisher
Dove Medical Press
Journal title
Language
English
Formats
Publication information
Publisher
Dove Medical Press
More information
Scope and Contents
Contents
Geoffrey S Dow, Alan J Magill, Colin OhrtDivision of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, MD, USAAbstract: Malaria is of continuing concern in nonimmune traveling populations. Traditionally, antimalarial drugs have been developed as agents for dual indications (treatment and prophylaxis). However, since...
Alternative Titles
Full title
Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f09a9ba1947548079b630c4cecdb7b3d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f09a9ba1947548079b630c4cecdb7b3d
Other Identifiers
ISSN
1176-6336
E-ISSN
1178-203X
